DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis
Public ClinicalTrials.gov record NCT02131324. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open Label, Study to Assess the Potential for Adrenal Suppression and Systemic Drug Absorption With DFD-06 Cream Versus Clobetasol Propionate Cream, 0.05% in Subjects With Moderate to Severe Plaque Psoriasis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the potential of DFD06 cream to suppress the HPA (hypothalamic-pituitary-adrenal) axis as compared to clobetasol propionate cream, 0.05% cream when applied twice daily for 15 days.
Study identification
- NCT ID
- NCT02131324
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 8, 2014 (Actual)
- Primary completion
- Apr 2016 (Actual)
- Completion
- Aug 11, 2016 (Actual)
- Last update posted
- May 18, 2018
2014 – 2016
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Research Associates | Glendale | Arizona | 85308 | — |
| Agave Clinical Research, LLC | Mesa | Arizona | 85202 | — |
| T. Joseph Raoof, MD, Inc. | Encino | California | 91436 | — |
| International Dermatology Research, Inc. | Miami | Florida | 33144 | — |
| FXM Research Corp. | Miami | Florida | 33175 | — |
| FXM Research Miramar | Miramar | Florida | 33027 | — |
| Belleair Research | Pinellas Park | Florida | 33781 | — |
| Forward Clinical Trials | Tampa | Florida | 33624 | — |
| Marietta Dermatology Clinical Research, Inc. | Marietta | Georgia | 30060 | — |
| Determatology Specialists Research, LLC | Louisville | Kentucky | 40202 | — |
| Quality Clinical Research, Inc. | Omaha | Nebraska | 68114 | — |
| Dermatology Consulting Services | High Point | North Carolina | 27262 | — |
| Lynn Health Science Institute | Oklahoma City | Oklahoma | 73112 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Radiant Research, Inc. | Greer | South Carolina | 29650 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02131324, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02131324 live on ClinicalTrials.gov.